In the news release, Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform, issued earlier today by Collexis Holdings Inc. (OTC Bulletin Board: CLXS) over PR Newswire, the disclaimer should read "Disclaimer: National Institutes of Health (NIH) and the CTSA consortium is not considered a supporter or partner of Collexis. Reference to NIH or CTSA consortium in the above shall not be construed as a Government endorsement nor does it obligate NIH to a position on or about the Collexis Software" rather than "Disclaimer: National Institutes of Health (NIH) is not considered a supporter or partner of Collexis. Reference to NIH in the above shall not be construed as a Government endorsement nor does it obligate NIH to a position on or about the Collexis Software" as incorrectly transmitted by PR Newswire.
Complete, corrected release follows:
Collexis Connects the NIH Clinical and Translational Science Award Programs
with CTSA Expert Platform CTSA Experts Platform launch will Enable 60,000+ Researchers at 38 Institutions to Collaborate
(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )
"Among the goals of the National Institutes of Health CTSA awards are to
accelerate bench to bedside discoveries into patient care, as well as to
develop the infrastructure to support ongoing collaborative efforts in
biomedical research," said Dr.
The new offering gives CTSA users a unique competitive advantage. It allows a researcher to identify partners from their organization and across the CTSA Consortia on any biomedical research topic(s). The platform automatically recommends collaborators from other institutions based on multiple areas of common research interests. Finally, the system will track and identify collaboration patterns among CTSA consortia members, allowing Collexis to give clients and NIH more information about how researchers work together and signaling ways that NIH can improve the CTSA program.
The Collexis Expert Platform approach to profiling life science
researchers has become the standard with research intensive institutions.
Current clients include
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and
knowledge discovery software is headquartered in
Disclaimer: National Institutes of Health (NIH) and the CTSA consortium is not considered a supporter or partner of Collexis. Reference to NIH or CTSA consortium in the above shall not be construed as a Government endorsement nor does it obligate NIH to a position on or about the Collexis Software.
Forward-Looking Statements
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties associated with the company's
CTSA Experts Platform. These risks and uncertainties are in addition to other
factors detailed from time to time in the company's filings with the SEC,
including the section entitled "Risk Factors" in its transition report on Form
10-K for the period ended
------
Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform
CTSA Experts Platform launch will Enable 60,000+ Researchers at 38 Institutions to Collaborate
(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )
"Among the goals of the National Institutes of Health CTSA awards are to
accelerate bench to bedside discoveries into patient care, as well as to
develop the infrastructure to support ongoing collaborative efforts in
biomedical research," said Dr.
The new offering gives CTSA users a unique competitive advantage. It allows a researcher to identify partners from their organization and across the CTSA Consortia on any biomedical research topic(s). The platform automatically recommends collaborators from other institutions based on multiple areas of common research interests. Finally, the system will track and identify collaboration patterns among CTSA consortia members, allowing Collexis to give clients and NIH more information about how researchers work together and signaling ways that NIH can improve the CTSA program.
The Collexis Expert Platform approach to profiling life science
researchers has become the standard with research intensive institutions.
Current clients include
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and
knowledge discovery software is headquartered in
Disclaimer: National Institutes of Health (NIH) is not considered a supporter or partner of Collexis. Reference to NIH in the above shall not be construed as a Government endorsement nor does it obligate NIH to a position on or about the Collexis Software.
Forward-Looking Statements
Some of the statements made in this press release may constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are based on
management's current expectations and include known and unknown risks,
uncertainties and other factors, many of which the company is unable to
predict or control, that may cause the company's actual results or performance
to differ materially from any future results or performance expressed or
implied by such forward-looking statements. These statements involve risks and
uncertainties, including risks and uncertainties associated with the company's
CTSA Experts Platform. These risks and uncertainties are in addition to other
factors detailed from time to time in the company's filings with the SEC,
including the section entitled "Risk Factors" in its transition report on Form
10-K for the period ended
SOURCE Collexis Holdings Inc.